Magenta Therapeutics, Inc. Gains 29.77%

Thu, Jul 07, 2022 at 08:37 PM
Magenta Therapeutics, Inc. Gains 29.77%

Magenta Therapeutics, Inc. (MGTA:NASDAQ) jumped higher at $1.7, a gain of 29.8%. On Thu, Jul 07, 2022, MGTA:NASDAQ touched a New 2-Week High of $1.7. From Thu, Jun 23, 2022, the stock recorded 44.44% Up Days and 50.00% Green Days

About Magenta Therapeutics, Inc. (MGTA:NASDAQ)

Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to bring the curative power of bone marrow transplant.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.